Search results for "OUTCOME"

showing 10 items of 5148 documents

Chelation treatment in sickle-cell-anaemia: much ado about nothing?

2011

Summary Blood transfusions may prevent and treat serious complications related to sickle-cell disease (SCD) when performed according to specific guidelines. However, blood transfusion requirements in SCD inevitably lead to increased body iron burden. An adequate chelation treatment may prevent complications and reduce morbidity and mortality. This review evaluates the effectiveness, safety and costs of chelation treatment. The included trials were examined according to the recommendations of the American College of Cardiology (ACC) and the American Heart Association (AHA). Overall, 14 trials and a total of 502 patients with SCD were included in this review. Deferoxamine alone (s.c. or i.v.)…

medicine.medical_specialtyPediatricsBlood transfusionDrug-Related Side Effects and Adverse Reactionsmedicine.medical_treatmentAnemia Sickle CellDiseaseIron Chelating Agentslaw.inventionBody ironchemistry.chemical_compoundRandomized controlled triallawmedicineHumansChelationIntensive care medicinebusiness.industryDeferasiroxHematologyChelation TherapyDeferoxamineTreatment OutcomechemistryCosts and Cost AnalysisDeferipronebusinessChelation treatment sickle-cell-diseasemedicine.drug
researchProduct

Recommendations for assessing Patient-Reported Outcomes and Health-Related quality of life in clinical trials on allergy: a GA2LEN taskforce position…

2010

The aim of this Global Allergy and Asthma European Network (GA(2)LEN) consensus report is to provide recommendations for patient-reported outcomes (PROs) evaluation in clinical trials for allergic diseases, which constitute a global health problem in terms of physical, psychological economic and social impact. During the last 40 years, PROs have gained large consideration and use in the scientific community, to gain a better understanding of patients' subjective assessment with respect to elements concerning their health condition. They include all health-related reports coming from the patient, without involvement or interpretation by physician or others. PROs assessment should be performe…

medicine.medical_specialtyPediatricsImmunologyPopulationMEDLINEAlergiaHypersensitivity; Humans; Treatment Outcome; Clinical Trials as Topic; Quality of Life; Outcome Assessment (Health Care); Data CollectionOutcome Assessment (Health Care)Quality of life (healthcare)Outcome Assessment Health CareGlobal healthmedicineHypersensitivityHumansImmunology and AllergyeducationAsmaeducation.field_of_studyClinical Trials as Topicbusiness.industryData CollectionGa2LenGuidelinehumanitiesClinical trialTreatment OutcomeFamily medicineInclusion and exclusion criteriaQuality of LifePosition paperbusinessQualidade de VidaHuman
researchProduct

Pantoprazole: from drug metabolism to clinical relevance.

2008

Conditions requiring inhibition of acid secretion, such as gastro-oesophageal reflux disease (GORD), peptic ulcers, non-ulcer dyspepsia or the use of NSAIDs, are very common, and their prevalence is expecting to rise as they are seen predominantly amongst the elderly. Among the drugs available to inhibit acid secretion, proton pump inhibitors (PPI) have been shown to have the best efficacy-safety ratio and have been used widely.This paper was intended to provide an overall presentation of one of these PPIs, pantoprazole.This study was first intended to give an overview of pantoprazole, so a Medline search was conducted using pantoprazole as unique search term, without publication date restr…

medicine.medical_specialtyPeptic UlcerPepticRabeprazoleLansoprazoleToxicologyGastroenterology2-PyridinylmethylsulfinylbenzimidazolesEsomeprazoleInternal medicinemedicineHumansPantoprazoleOmeprazolePantoprazolePharmacologyClinical Trials as Topicbiologybusiness.industryProton Pump InhibitorsGeneral MedicineHelicobacter pyloribiology.organism_classificationAnti-Ulcer Agentsdigestive system diseasesTreatment OutcomeGastroesophageal RefluxbusinessDrug metabolismmedicine.drugExpert opinion on drug metabolismtoxicology
researchProduct

Standard Outcome Indicators After Colon Cancer Resection. Creation of a Nomogram for Autoevaluation

2016

Abstract Introduction Lately there has been an increasing interest in identifying quality standards in different pathologies, among them colon cancer due to its great prevalence. The main goal of this study is to define the quality standards of colon cancer surgery based on a large prospective national study dataset. Methods Data from the prospective national study ANACO were used. This study included a consecutive series of patients operated on for colon cancer in 52 Spanish hospitals (2011–2012). Centers with less than 30 patients were excluded. The present analysis finally included 42 centers (2975 patients). Based on the results obtained in 4 main indicators from each hospital (anastomo…

medicine.medical_specialtyPercentilebusiness.industryColorectal cancerMortality ratemedicine.medical_treatmentGeneral Engineering030230 surgeryNomogramAnastomosismedicine.diseaseSurgeryNomograms03 medical and health sciences0302 clinical medicineColon surgery030220 oncology & carcinogenesisColonic NeoplasmsOutcome Assessment Health CareColon cancer resectionHumansMedicinebusinessColectomyColectomyCirugía Española (English Edition)
researchProduct

Temporal trends in postinfarction ventricular septal rupture: the CIVIAM Registry

2020

Abstract Introduction and objectives Postinfarction ventricular septal rupture is a rare but severe complication of myocardial infarction with high mortality rates. Our goal was to analyze which factors could have an impact on mortality due to this entity over the past decade, including those related to mechanical circulatory support . Methods The CIVIAM registry is an observational, retrospective, multicenter study carried out in Spain. We designed a comparative analysis, focused on description of in-hospital management and in-hospital and 1-year total mortality as the primary endpoints, dividing the total observation time into 2 equal temporal periods (January 2008 to June2013 and July 20…

medicine.medical_specialtyPercutaneousMyocardial Infarction030204 cardiovascular system & hematologyExtracorporealVentricular Septal Rupture03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineHumansRegistriesMyocardial infarctionRetrospective StudiesVentricular Septal Rupturebusiness.industryCardiogenic shockConfoundingGeneral Medicinemedicine.diseaseSurvival RateTreatment OutcomeConventional PCICirculatory systemCardiologybusinessRevista Española de Cardiología (English Edition)
researchProduct

Biodegradable polymer-coated thin strut sirolimus- -eluting stent versus durable polymer-coated everolimus-eluting stent in the diabetic population.

2021

Background: The number of patients with diabetes mellitus (DM) presenting with coronary artery disease is increasing and accounts for more than 30% of patients undergoing percutaneous coronary interventions (PCI). The biodegradable polymer drug-eluting stents were developed to improve vascular healing. It was sought herein, to determine 1-year clinical follow-up in patients with DM treated with the thin strut biodegradable polymer-coated sirolimus-eluting stent (BP-SES) versus durable coating everolimus-eluting stent (DP-EES). Methods: Patients were retrospectively analyzed with DM were treated with either a BP-SES (ALEX™, Balton, Poland, n = 670) or a DP-EES (XIENCE™, Abbott, USA, n = 884)…

medicine.medical_specialtyPercutaneousPolymersmedicine.medical_treatmentPopulation030204 cardiovascular system & hematologyProsthesis DesignCoronary artery disease03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionInternal medicineAbsorbable ImplantsDiabetes MellitusMedicineHumansMyocardial infarctionEverolimuseducationRetrospective StudiesSirolimuseducation.field_of_studybusiness.industryStentPercutaneous coronary interventionCardiovascular AgentsDrug-Eluting StentsGeneral Medicinemedicine.diseaseInterventional CardiologySurgeryTreatment OutcomeSirolimusConventional PCICardiologyPolandCardiology and Cardiovascular Medicinebusinessmedicine.drugCardiology journal
researchProduct

Patient selection, echocardiographic screening and treatment strategies for interventional tricuspid repair using the edge-to-edge repair technique

2018

Severe tricuspid regurgitation (TR) has long been neglected despite its well-known association with mortality. While surgical mortality rates remain high in isolated tricuspid valve surgery, interventional TR repair is rapidly evolving as an alternative to cardiac surgery in selected patients at high surgical risk. Currently, interventional edge-to-edge repair is the most frequently applied technique for TR repair even though a device has not been developed for this particular indication. Due to the inherent differences in tricuspid and mitral valve anatomy and pathology, percutaneous repair of the tricuspid valve is challenging due to a variety of factors including the complexity and varia…

medicine.medical_specialtyPercutaneousProcedural approach610 Medicine & healthRegurgitation (circulation)030204 cardiovascular system & hematology2705 Cardiology and Cardiovascular Medicine03 medical and health sciences0302 clinical medicineMitral valveHumansMedicinecardiovascular diseases030212 general & internal medicineTRICUSPID VALVE REPAIRHeart Valve Prosthesis ImplantationTricuspid valvebusiness.industryPatient SelectionMitral Valve InsufficiencyTricuspid Valve InsufficiencyCardiac surgery10020 Clinic for Cardiac SurgeryTreatment Outcomemedicine.anatomical_structureEchocardiographycardiovascular systemTreatment strategyTricuspid ValveRadiologyCardiology and Cardiovascular Medicinebusiness
researchProduct

Resistance of the internal mammary artery to restenosis: a histomorphologic study of various porcine arteries.

2007

<i>Background/Aims:</i> Restenosis after percutaneous transluminal angioplasty (PTA) of the internal mammary artery (IMA) grafts is much less pronounced than in other arteries and venous grafts. The aim of the study was to test whether various arteries respond differently to dilatation. <i>Methods:</i> PTA of the IMA, carotid, renal and circumflex coronary (RCx) arteries was performed in 9 pigs (balloon to artery ratio of 1:1.5). After 8 weeks, angiography was repeated and vessels prepared for histological analysis. Immunohistochemical staining was done to examine proliferative activity (Ki67) and to identify the vasa vasorum of the adventitia (F VIII-RA). <i>R…

medicine.medical_specialtyPercutaneousTime FactorsPhysiologySwinemedicine.medical_treatmenteducationRenal Artery ObstructionCoronary AngiographyRenal Artery ObstructionCoronary RestenosisRenal ArteryRestenosisInternal medicinemedicine.arteryAngioplastyotorhinolaryngologic diseasesmedicineMitotic IndexAnimalsCarotid StenosisRenal arteryAngioplasty Balloon CoronaryMammary ArteriesCell Proliferationmedicine.diagnostic_testbusiness.industryAngiographyGraft Occlusion Vascularmedicine.diseaseTunica intimaCoronary VesselsImmunohistochemistrysurgical procedures operativemedicine.anatomical_structureCarotid ArteriesTreatment OutcomeAngiographyCirculatory systemModels AnimalCardiologyCardiology and Cardiovascular MedicinebusinessTunica IntimaTunica MediaAngioplasty BalloonJournal of vascular research
researchProduct

Craniofacial venous malformations treated by percutaneous sclerotherapy using polidocanol: a single-center experience.

2018

Background Percutaneous therapy with various sclerosants is an established treatment of venous malformations in general. We investigated the safety and effectiveness of polidocanol in the craniofacial region. Purpose To present and evaluate our subjective and objective mid- and long-term results of patients with craniofacial venous malformations (CFVM) after percutaneous sclerotherapy using polidocanol. Material and Methods Twenty patients with CFVM treated by percutaneous sclerotherapy were followed up and asked to fill in a questionnaire comparing levels of the following CFVM-related symptoms before and after treatment: pain; functional impairment; cosmetic deformities; and impairment in …

medicine.medical_specialtyPercutaneousVascular Malformationsmedicine.medical_treatmentPolidocanol030204 cardiovascular system & hematologySingle Center030218 nuclear medicine & medical imagingPolidocanol03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesSclerotherapymedicineSclerotherapyHumansRadiology Nuclear Medicine and imagingCraniofacialRetrospective StudiesRadiological and Ultrasound Technologybusiness.industryHead neckGeneral MedicineSclerosing SolutionsSurgeryTreatment OutcomeFacebusinessNeckmedicine.drugActa radiologica (Stockholm, Sweden : 1987)
researchProduct

Fully Percutaneous Transaxillary Aortic Valve Replacement With Effective Bailout Plan for Vascular Complications.

2020

medicine.medical_specialtyPercutaneousbusiness.industryAortic Valve StenosisTAVRsubclavian approachtransaxillary TAVRmedicine.diseaseSurgeryTAVITranscatheter Aortic Valve ReplacementPostoperative ComplicationsTreatment Outcometransaxillary TAVIAortic valve replacementRisk FactorsAortic ValveHeart Valve ProsthesismedicineHumansCardiology and Cardiovascular MedicinebusinessBailoutJACC. Cardiovascular interventions
researchProduct